UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

Rheumatology (Oxford, England), 2010-02, Vol.49 (2), p.295-307

2010

Volltextzugriff (PDF)

Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

Rheumatology (Oxford, England), 2011-03, Vol.50 (3), p.518-531

2011

Volltextzugriff (PDF)

Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician

Biologics, 2021-01, Vol.15, p.343-352

2021

Volltextzugriff (PDF)

Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double‐Blind, Randomized Controlled Trial

Arthritis & rheumatology (Hoboken, N.J.), 2019-11, Vol.71 (11), p.1788-1800

2019

Volltextzugriff (PDF)

Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study

Rheumatology and therapy., 2017-06, Vol.4 (1), p.85-96

2017

Volltextzugriff (PDF)

Contemporary treatment principles for early rheumatoid arthritis: a consensus statement

Rheumatology (Oxford, England), 2009-07, Vol.48 (7), p.765-772

2009

Volltextzugriff (PDF)

Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials

Rheumatic & musculoskeletal diseases open, 2022-03, Vol.8 (1), p.e002049

2022

Volltextzugriff (PDF)

Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2

Rheumatic & musculoskeletal diseases open, 2022-06, Vol.8 (2), p.e002286

2022

Volltextzugriff (PDF)

Impact of a Patient Support Program on time to discontinuation of adalimumab in Australian adult patients with immune-mediated inflammatory diseases-an observational study

PloS one, 2024-06, Vol.19 (6), p.e0300624

2024

Volltextzugriff (PDF)

Pulmonary adverse events of small molecule JAK inhibitors in autoimmune disease: systematic review and meta-analysis

Rheumatology (Oxford, England), 2020-09, Vol.59 (9), p.2217-2225

2020

Volltextzugriff (PDF)

Erratum to: Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study

Rheumatology and therapy., 2017-06, Vol.4 (1), p.97-97

2017

Volltextzugriff (PDF)

Time to flare in giant cell arteritis and polymyalgia rheumatica: analysis from a single‐centre Australian practice

Internal medicine journal, 2024-05, Vol.54 (5), p.838-839

2024

Volltextzugriff (PDF)

Immune checkpoint inhibitor‐induced lymphocytic fasciitis

Internal medicine journal, 2018-12, Vol.48 (12), p.1550-1552

2018

Volltextzugriff (PDF)

Value of Remission in Patients with Rheumatoid Arthritis: A Targeted Review

Advances in therapy, 2022-01, Vol.39 (1), p.75-93

2022

Volltextzugriff (PDF)

Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice

Annals of the rheumatic diseases, 2012-12, Vol.71 (12), p.1950-1954

2012

Volltextzugriff (PDF)

Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution

Postgraduate Medical Journal, 2007-04, Vol.83 (978), p.251-260

2007

Volltextzugriff (PDF)

Non-infectious pulmonary complications of newer biological agents for rheumatic diseases-a systematic literature review

Rheumatology (Oxford, England), 2011-12, Vol.50 (12), p.2297-2305

2011

Volltextzugriff (PDF)

Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies

Arthritis research & therapy, 2016-12, Vol.18 (1), p.302-302, Article 302

2016

Volltextzugriff (PDF)

Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review

Clinical rheumatology, 2011-11, Vol.30 (11), p.1471-1474

2011

Volltextzugriff (PDF)

Tapering versus steady-state methotrexate in combination with tocilizumab for rheumatoid arthritis: a randomized, double-blind trial

Rheumatology (Oxford, England), 2018-01, Vol.57 (1), p.84-91

2018

Volltextzugriff (PDF)

Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension

Rheumatic & musculoskeletal diseases open, 2022-07, Vol.8 (2), p.e002280

2022

Volltextzugriff (PDF)

TNF antagonists and shingles: is vaccination advisable?

Annals of the rheumatic diseases, 2013-05, Vol.72 (5), p.e1-e1

2013

Volltextzugriff (PDF)

Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort

Clinical rheumatology, 2014-05, Vol.33 (5), p.609-614

2014

Volltextzugriff (PDF)

Orbital Cellulitis in a Patient Receiving Infliximab for Ankylosing Spondylitis

American journal of ophthalmology, 2006-04, Vol.141 (4), p.767-769

2006

Volltextzugriff (PDF)

The prevalence and impact of polypharmacy in rheumatology

Rheumatology (Oxford, England), 2023-10, Vol.62 (SI3), p.SI237-SI241

2023

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(105)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(92)
Science & Technology
(90)
Life Sciences & Biomedicine
(89)
Rheumatology
(68)
Arthritis, Rheumatoid - Drug Therapy
(45)
Rheumatoid Arthritis
(44)
Female
(38)
Antirheumatic Agents - Therapeutic Use
(35)
Middle Aged
(32)
Adult
(30)
Male
(30)
Biological And Medical Sciences
(26)
Medical Sciences
(26)
Treatment Outcome
(25)
Aged
(24)
Medicine
(20)
Medicine & Public Health
(20)
Antirheumatic Agents - Adverse Effects
(19)
Diseases Of The Osteoarticular System
(18)
Arthritis
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician

Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double‐Blind, Randomized Controlled Trial

Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study

Contemporary treatment principles for early rheumatoid arthritis: a consensus statement

Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials

Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2

Impact of a Patient Support Program on time to discontinuation of adalimumab in Australian adult patients with immune-mediated inflammatory diseases-an observational study

Pulmonary adverse events of small molecule JAK inhibitors in autoimmune disease: systematic review and meta-analysis

Erratum to: Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study

Time to flare in giant cell arteritis and polymyalgia rheumatica: analysis from a single‐centre Australian practice

Immune checkpoint inhibitor‐induced lymphocytic fasciitis

Value of Remission in Patients with Rheumatoid Arthritis: A Targeted Review

Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice

Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution

Non-infectious pulmonary complications of newer biological agents for rheumatic diseases-a systematic literature review

Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies

Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review

Tapering versus steady-state methotrexate in combination with tocilizumab for rheumatoid arthritis: a randomized, double-blind trial

Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension

TNF antagonists and shingles: is vaccination advisable?

Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort

Orbital Cellulitis in a Patient Receiving Infliximab for Ankylosing Spondylitis

The prevalence and impact of polypharmacy in rheumatology

Suchergebnisse filtern